Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Anim Biosci ; 34(7): 1105-1115, 2021 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32777894

RESUMEN

OBJECTIVE: To conserve and utilize the genetic resources of a traditional Chinese indigenous pig breed, Liangshan pig, we assessed the genetic diversity, genetic structure, and genetic distance in this study. METHODS: We used 50K single nucleotide polymorphism (SNP) chip for SNP detection of 139 individuals in the Liangshan Pig Conservation Farm. RESULTS: The genetically closed conserved population consisted of five overlapping generations, and the total effective content of the population (Ne) was 15. The whole population was divided into five boar families and one non-boar family. Among them, the effective size of each generation subpopulation continuously decreased. However, the proportion of polymorphic markers (PN) first decreased and then increased. The average genetic distance of these 139 Liangshan pigs was 0.2823±0.0259, and the average genetic distance of the 14 boars was 0.2723±0.0384. Thus, it can be deduced that the genetic distance changed from generation to generation. In the conserved population, 983 runs of homozygosity (ROH) were detected, and the majority of ROH (80%) were within 100 Mb. The inbreeding coefficient calculated based on ROH showed an average value of 0.026 for the whole population. In addition, the inbreeding coefficient of each generation subpopulation initially increased and then decreased. In the pedigree of the whole conserved population, the error rate of paternal information was more than 11.35% while the maternal information was more than 2.13%. CONCLUSION: This molecular study of the population genetic structure of Liangshan pig showed loss of genetic diversity during the closed cross-generation reproduction process. It is necessary to improve the mating plan or introduce new outside blood to ensure longterm preservation of Liangshan pig.

2.
Gut Microbes ; 13(1): 1-19, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33550882

RESUMEN

Betaine is a natural compound present in commonly consumed foods and may have a potential role in the regulation of glucose and lipids metabolism. However, the underlying molecular mechanism of its action remains largely unknown. Here, we show that supplementation with betaine contributes to improved high-fat diet (HFD)-induced gut microbiota dysbiosis and increases anti-obesity strains such as Akkermansia muciniphila, Lactobacillus, and Bifidobacterium. In mice lacking gut microbiota, the functional role of betaine in preventing HFD-induced obesity, metabolic syndrome, and inactivation of brown adipose tissues are significantly reduced. Akkermansia muciniphila is an important regulator of betaine in improving microbiome ecology and increasing strains that produce short-chain fatty acids (SCFAs). Increasing two main members of SCFAs including acetate and butyrate can significantly regulate the levels of DNA methylation at host miR-378a promoter, thus preventing the development of obesity and glucose intolerance. However, these beneficial effects are partially abolished by Yin yang (YY1), a common target gene of the miR-378a family. Taken together, our findings demonstrate that betaine can improve obesity and associated MS via the gut microbiota-derived miR-378a/YY1 regulatory axis, and reveal a novel mechanism by which gut microbiota improve host health.


Asunto(s)
Fármacos Antiobesidad/farmacología , Betaína/farmacología , Microbioma Gastrointestinal/efectos de los fármacos , MicroARNs/genética , Obesidad/prevención & control , Animales , Fármacos Antiobesidad/administración & dosificación , Bacterias/clasificación , Bacterias/crecimiento & desarrollo , Bacterias/metabolismo , Betaína/administración & dosificación , Dieta Alta en Grasa/efectos adversos , Suplementos Dietéticos , Ácidos Grasos Volátiles/metabolismo , Femenino , Síndrome Metabólico/etiología , Síndrome Metabólico/genética , Síndrome Metabólico/microbiología , Síndrome Metabólico/prevención & control , Ratones , Obesidad/etiología , Obesidad/genética , Obesidad/microbiología , Factor de Transcripción YY1/genética
3.
Nutrients ; 10(2)2018 Jan 26.
Artículo en Inglés | MEDLINE | ID: mdl-29373534

RESUMEN

Obesity is a major driver of metabolic diseases such as nonalcoholic fatty liver disease, certain cancers, and insulin resistance. However, there are no effective drugs to treat obesity. Betaine is a nontoxic, chemically stable and naturally occurring molecule. This study shows that dietary betaine supplementation significantly inhibits the white fat production in a high-fat diet (HFD)-induced obese mice. This might be due to betaine preventing the formation of new white fat (WAT), and guiding the original WAT to burn through stimulated mitochondrial biogenesis and promoting browning of WAT. Furthermore, dietary betaine supplementation decreases intramyocellular lipid accumulation in HFD-induced obese mice. Further analysis shows that betaine supplementation reduced intramyocellular lipid accumulation might be associated with increasing polyunsaturated fatty acids (PUFA), fatty acid oxidation, and the inhibition of fatty acid synthesis in muscle. Notably, by performing insulin-tolerance tests (ITTs) and glucose-tolerance tests (GTTs), dietary betaine supplementation could be observed for improvement of obesity and non-obesity induced insulin resistance. Together, these findings could suggest that inhibiting WAT production, intramyocellular lipid accumulation and inflammation, betaine supplementation limits HFD-induced obesity and improves insulin resistance.


Asunto(s)
Adiposidad , Fármacos Antiobesidad/uso terapéutico , Betaína/uso terapéutico , Suplementos Dietéticos , Resistencia a la Insulina , Metabolismo de los Lípidos , Obesidad/dietoterapia , Células 3T3-L1 , Adipocitos Blancos/citología , Adipocitos Blancos/metabolismo , Adipocitos Blancos/patología , Adipogénesis , Animales , Animales no Consanguíneos , Betaína/efectos adversos , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/dietoterapia , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Experimental/patología , Dieta Alta en Grasa/efectos adversos , Femenino , Hiperglucemia/prevención & control , Hipoglucemiantes/uso terapéutico , Gotas Lipídicas/metabolismo , Gotas Lipídicas/patología , Ratones , Músculo Esquelético/metabolismo , Músculo Esquelético/patología , Obesidad/etiología , Obesidad/metabolismo , Obesidad/patología , Aumento de Peso
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA